Skip to main content
SpringerLink
Log in
Book cover

Chemokine Biology — Basic Research and Clinical Application pp 165–182Cite as

Virus-encoded chemokine modulators as novel anti-inflammatory reagents

  • Chapter

Part of the book series: Progress in Inflammation Research ((PIR))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alcami A, Koszinowski UH (2000) Viral mechanisms of immune evasion. Immunol Today 21: 447–455

    CAS  PubMed  Google Scholar 

  2. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL (2000) Viral subversion of the immune system. Ann Rev Immunol 18: 861–926

    Article  CAS  Google Scholar 

  3. Agrawal N, Korkaya H, Jameel S (2000) How viruses evade host responses [Review]. Curr Sci 79: 711–724

    CAS  Google Scholar 

  4. Rosenkilde MM, Walkhoer M, Luttichau HR, Schwartz TW (2001) Virally encoded 7TM receptors. Oncogene 20: 1582–1593

    Article  CAS  PubMed  Google Scholar 

  5. Xu X-N, Screaton GR, McMichael AJ (2001) Virus Infections: Escape resistance, and counterattack. Immunity 15: 867–870

    Article  CAS  PubMed  Google Scholar 

  6. Lorenzo ME, Ploegh HL, Tirabassi RS (2001) Viral immune evasion strategies and the underlying cell biology. Immunology 13: 1–9

    CAS  Google Scholar 

  7. Gewurz BE, Gaudet R, Tortorella D, Wang EW, Ploegh HL (2001) Virus subversion of immunity: A structural perspective. Curr Op Immunol 13: 442–450

    CAS  Google Scholar 

  8. Vossen MTM, Westerhout EM, Soderberg-Naucler C, Wiertz EJHJ (2002) Viral immune evasion: A masterpiece of evolution. Immunogenetics 54: 527–542

    Article  CAS  PubMed  Google Scholar 

  9. Petersen JL, Morris CR, Solheim JC (2003) Virus evasion of MHC Class I molecule presentation. J Immunol 171: 4473–4478

    CAS  PubMed  Google Scholar 

  10. Alcami A (2003) Viral mimicry of cytokines, chemokines and their receptors. Nature Rev Immunol 3: 36–50

    CAS  Google Scholar 

  11. McFadden G, Murphy PM (2000) Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr Op Microbiol 3: 371–378

    CAS  Google Scholar 

  12. Smith GL (2000) Secreted poxvirus proteins that interact with the immune system In: RS Fujinami (ed): Effects of Microbes on the Immune System. Lippincott Williams and Wilkins, Philadelphia, 491–507

    Google Scholar 

  13. Moss B, Shisler JL (2001) Immunology 101 at poxvirus U: Immune evasion genes. Semin Immunol 13: 59–66

    Article  CAS  PubMed  Google Scholar 

  14. Johnston JB, McFadden G (2003) Poxvirus immunomodulatory strategies: Current perspectives. J Virol 77: 6093–6100

    CAS  PubMed  Google Scholar 

  15. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G (2003) Poxviruses and immune evasion. Ann Rev Immunol 21: 377–423

    Article  CAS  Google Scholar 

  16. Shchelkunov SN (2003) Immunomodulatory proteins of orthopoxviruses. Mol Biol 37: 37–48

    Article  CAS  Google Scholar 

  17. Lalani AS, Barrett J, McFadden G (2000) Modulating chemokines: More lessons from viruses. Immunol Today 21: 100–106

    Article  CAS  PubMed  Google Scholar 

  18. Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nature 2: 116–122

    CAS  Google Scholar 

  19. Seet BT, McFadden G (2002) Viral chemokine binding proteins. J Leukocyte Biol 72: 24–34

    CAS  PubMed  Google Scholar 

  20. Holst PJ, Rosenkilde MM (2003) Microbiological exploitation of the chemokine system. Microb Infect 5: 179–187

    CAS  Google Scholar 

  21. Saederup N, Mocarski J (2002) Fatal attraction: Cytomegalovirus-encoded chemokine homologs. Curr Top Microbiol Immunol 269: 235–256

    CAS  PubMed  Google Scholar 

  22. Kotwal GJ (2000) Poxviral mimicry of complement and chemokine system components: What’s the end game? Immunol Today 21: 242–248

    Article  CAS  PubMed  Google Scholar 

  23. Liston A, McColl S (2003) Subversion of the chemokine world by microbial pathogens. BioEssays 25: 478–488

    Article  CAS  PubMed  Google Scholar 

  24. Dairaghi DJ, Greaves DR, Schall TJ (1998) Abduction of chemokine elements by herpesviruses. Semin Virol 8: 377–385

    Article  CAS  Google Scholar 

  25. Chensue SW (2001) Molecular machinations: Chemokine signals in host-pathogen interactions. Clin Microbiol Rev 14: 821–835

    Article  CAS  PubMed  Google Scholar 

  26. Lalani AS, McFadden G (1999) Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev 10: 219–233

    Article  CAS  PubMed  Google Scholar 

  27. Sodhi A, Mantaner S, Gutkind JS (2004) Viral hijacking of G-protein coupled-receptor signalling networks. Nature Rev/Mol Cell Biol 5: 998–1012

    CAS  Google Scholar 

  28. Lucas A, McFadden G (2004) Secreted immunomodulatory viral proteins as novel biotherapeutics. J Immunol 173: 4765–4774

    CAS  PubMed  Google Scholar 

  29. Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious disease. Blood 95: 3032–3043

    CAS  PubMed  Google Scholar 

  30. Zlotnik A, Yoshie O (2000) Chemokines: A new classification system and their role in immunity. Immunity 12: 121–127

    Article  CAS  PubMed  Google Scholar 

  31. Rot A, Von Andrian UH (2004) Chemokines in innate and adaptive host defense: Basic chemokinese grammar for immune cells. Ann Rev Immunol 22: 891–928

    Article  CAS  Google Scholar 

  32. Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: Multiple levels of leukocyte migration control. Trends Immunol 25: 75–84

    Article  CAS  PubMed  Google Scholar 

  33. Mackay CR (2001) Chemokines: Immunology’s high impact factor. Nature 2: 95–101

    CAS  Google Scholar 

  34. Fernandez EJ, Lolis E (2001) Structure, function, and inhibition of chemokines. Ann Rev Pharmacol Tox 42: 469–499

    Google Scholar 

  35. Proudfoot AEI (2002) Chemokine receptors: Multifaceted therapeutic targets. Nature Rev Immunol 2: 106–115

    CAS  Google Scholar 

  36. Ali S, Palmer ACV, Banerjee B, Fritchley SJ, Kirby JA (2000) Examination of the function of RANTES, MIP-1a, and MIP-1b following interaction with heparin-like glycosaminoglycans. J Biol Chem 275: 11721–11727

    CAS  PubMed  Google Scholar 

  37. Campbell DJ, Kim CH, Butcher EC (2003) Chemokines in the systemic organization of immunity. Immunol Rev 195: 58–71

    Article  CAS  PubMed  Google Scholar 

  38. Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Rickle T, Camps M, Wells TNC, Schwarz MK, Proudfoot AEI et al (2004) Chemokine inhibition — Why, when, where, which and how? Biochem Soc Trans 32: 366–377

    CAS  PubMed  Google Scholar 

  39. Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858–866

    Article  CAS  PubMed  Google Scholar 

  40. Barry M, McFadden G (1997) Virokines and viroceptors In: JS Friedland (ed): Cytokines in Health and Disease. Marcel Dekker Inc, New York, 251–261

    Google Scholar 

  41. Barry M, McFadden G (1997) Virus encoded cytokines and cytokine receptors. Parasitology 115: S89–S100

    Article  PubMed  Google Scholar 

  42. Alcamí A, Koszinowski UH (2000) Viral mechanisms of immune evasion. Immunol Today 21: 447–455

    PubMed  Google Scholar 

  43. Upton C, Slack S, Hunter AL, Ehlers A, Roper RL (2003) Poxvirus orthologous clusters: Toward defining the minimum essential poxvirus genome. J Virol 77: 7590–7600

    Article  CAS  PubMed  Google Scholar 

  44. McLysaght A, Baldi PF, Gaut BS (2003) Extensive gene gain associated with adaptive evoluton of poxviruses. Proc Nat Acad Sci USA 100: 15655–15660

    Article  CAS  PubMed  Google Scholar 

  45. Gubser C, Hue S, Kellam P, Smith GL (2004) Poxvirus genomes: A phylogenetic analysis. J Gen Virol 85: 105–117

    Article  CAS  PubMed  Google Scholar 

  46. Smith SA, Kotwal GJ (2001) Virokines: Novel immunomodulatory agents. Expert Op Biol Ther 1: 343–357

    CAS  Google Scholar 

  47. McFadden G, Lalani A, Everett H, Nash P, Xu X (1998) Virus encoded-receptors for cytokines and chemokines. Semin Cell Develop Biol 9: 359–368

    CAS  Google Scholar 

  48. Carfi A, Smith CA, Smolak PJ, McGrew J, Wiley DC (1999) Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. Proc Nat Acad Sci USA 96: 12379–12383

    Article  CAS  PubMed  Google Scholar 

  49. Alexander JM, Nelson CA, Van Berkel V, Lau EK, Studts JM, Brett TJ, Speck SH, Handel TM, Virgin HW, Fremont DH (2002) Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 111: 343–356

    Article  CAS  PubMed  Google Scholar 

  50. Alcami A (2003) Structural basis of the herpesvirus M3-chemokine interaction. Trends Microbiol 11: 191–192

    CAS  PubMed  Google Scholar 

  51. Lalani AS, Graham K, Mossman K, Rajarathnam K, Clark-Lewis I, Kelvin D, McFadden G (1997) The purified myxoma virus gamma interferon receptor homolog, M-T7, interacts with the heparin binding domains of chemokines. J Virol 71: 4356–4363

    CAS  PubMed  Google Scholar 

  52. Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G (1996) Myxoma virus M-T7, a secreted homolog of the interferon-g receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virol 215: 17–30

    CAS  Google Scholar 

  53. Upton C, Mossman K, McFadden G (1992) Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258: 1369–1372

    CAS  PubMed  Google Scholar 

  54. Alcamí A, Symons JA, Collins PD, Williams TJ, Smith GL (1998) Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol 160: 624–633

    PubMed  Google Scholar 

  55. Smith CA, Smith TD, Smolak PJ, Friend D, Hagen H, Gerhart M, Park L, Pickup DJ, Torrance D, Mohler K et al (1997) Poxvirus genomes encode a secreted soluble protein that preferentially inhibits b chemokine activity yet lacks sequence homology to known chemokine receptors. Virol 236: 316–327

    CAS  Google Scholar 

  56. Graham KA, Lalani AS, Macen JL, Ness TL, Barry M, Liu L-Y, Lucas A, Clark-Lewis I, Moyer RW, McFadden G (1997) The T1/35kDa family of poxvirus secreted proteins bind chemokines and modulate leukocyte influx into virus infected tissues. Virol 229: 12–24

    CAS  Google Scholar 

  57. Lalani AS, Ness TL, Singh R, Harrison JK, Seet BT, Kelvin DJ, McFadden G, Moyer RW (1998) Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250: 173–184

    Article  CAS  PubMed  Google Scholar 

  58. Reading PC, Symons JA, Smith GL (2003) A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J Immunol 170: 1435–1442

    CAS  PubMed  Google Scholar 

  59. Van Berkel V, Barrett J, Tiffany HL, Fremont DH, Murphy PM, McFadden G, Speck SH, Virgin HW (2000) Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 74: 6741–6747

    PubMed  Google Scholar 

  60. Parry BC, Simas JP, Smith VP, Stewart CA, Minson AC, Efstathiou S, Alcamí A (2000) A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 191: 573–578

    Article  CAS  PubMed  Google Scholar 

  61. Alcami A, Efstathiou S (2000) Soluble chemokine binding proteins are also encoded by herpesviruses. Immunol Today 21: 526–527

    CAS  PubMed  Google Scholar 

  62. Webb LMC, Clark-Lewis I, Alcami A (2003) The gammaherpesvirus chemokine binding protein binds to the N terminus of CXCL8. J Virol 77: 8588–8592

    Article  CAS  PubMed  Google Scholar 

  63. Webb LMC, Smith VP, Alcami A (2004) The gammaherpesvirus chemokine binding protein can inhibit the interaction of chemokines with glycosaminoglycans. FASEB J 18: 571–573

    CAS  PubMed  Google Scholar 

  64. Bridgeman A, Stevenson PG, Simas JP, Efstathiou S (2001) A secreted chemokine binding protein encoded by murine gammaherpesvirus-68 is necessary for the establishment of a normal latend load. J Exp Med 194: 301–312

    Article  CAS  PubMed  Google Scholar 

  65. Van Berkel V, Levine B, Kapadia SB, Goldman JE, Speck SH, Virgin HWT (2002) Critical role for a high-affinity chemokine-binding protein in g-herpesvirus-induced lethal meningitis. J Clin Invest 109: 905–914

    PubMed  Google Scholar 

  66. Bryant NA, Davis-Poynter N, Vanderplasschen A, Alcami A (2003) Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins. EMBO J 22: 833–846

    Article  CAS  PubMed  Google Scholar 

  67. Wang D, Bresnahan W, Shenk T (2004) Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc Nat Acad Sci USA 101: 16642–16647

    CAS  PubMed  Google Scholar 

  68. Lindow M, Luttichau HR, Schwartz TW (2003) Viral leads for chemokine-modulatory drugs. Trends Pharmacol Sci 24: 126–130

    Article  CAS  PubMed  Google Scholar 

  69. Proudfoot AEI, Power CA, Rommel C, Wells TNC (2003) Strategies for chemokine antagonists as therapeutics. Semin Immunol 15: 57–65

    Article  CAS  PubMed  Google Scholar 

  70. Schwarz MK, Wells TN (2002) New therapeutics that modulate chemokine networks. Nature Rev Drug Dis 1: 347–358

    CAS  Google Scholar 

  71. Houshmand P, Zlotnik A (2003) Therapeutic applications in the chemokine superfamily. Curr Op Chem Biol 7: 457–460

    CAS  Google Scholar 

  72. Grainer DJ, Reckless J (2003) Broad-spectrum chemokine inhibitors (BSCIs) and their anti-inflammatory effects in vivo. Biochem Pharmacol 65: 1027–1034

    Google Scholar 

  73. Onuffer JJ, Horuk R (2002) Chemokines, chemokine receptors and small-molecule antagonists: Recent developments. Trends Pharmacol Sci 23: 459–467

    Article  CAS  PubMed  Google Scholar 

  74. Rajarathnam K (2002) Designing decoys for chemokine-chemokine receptor interaction. Curr Phama Design 8: 2159–2169

    CAS  Google Scholar 

  75. Liu LY, Lalani A, Dai E, Seet B, Macauley C, Singh R, Fan L, McFadden G, Lucas A (2000) The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury. J Clin Invest 105: 1613–1621

    CAS  PubMed  Google Scholar 

  76. Bedard ELR, Kim P, Jiang J, Parry N, Liu L, Wang H, Garcia B, Li X, McFadden G, Lucas A et al (2003) Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76: 249–252

    CAS  PubMed  Google Scholar 

  77. Liu L, Dai E, Miller L, Seet B, Lalani A, Macauley C, Li X, Virgin HW, Bunce C, Turner P et al (2004) Viral chemokine-binding proteins inhibit inflammatory responses and aortic allograft transplant vasculopathy in rat models. Transplantation 77: 1652–1660

    CAS  PubMed  Google Scholar 

  78. Dabbagh K, Xiao Y, Smith C, Stepick-Biek P, Kim SG, Lamm WJ, Liggitt DH, Lewis DB (2000) Local blockade of allergic airway hyperreactivity and inflammation by the poxvirus-derived pan-CC-chemokine inhibitor vCCI. J Immunol 165: 3418–3422

    CAS  PubMed  Google Scholar 

  79. Bursill CA, Cai S, Channon KM, Greaves DR (2003) Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo. Immunol 207: 187–196

    CAS  Google Scholar 

  80. Bursill CA, Choudbury RP, Ali Z, Greaves DR, Channon KM (2004) Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipopritein E-knockout mice. Circulation 110: 2460–2466

    Article  CAS  PubMed  Google Scholar 

  81. Jensen KK, Chen S-C, Hipkin RW, Wiekowski MT, Schwarz MA, Chou C-C, Simas JP, Alcami A, Lira SA (2003) Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol 77: 624–630

    CAS  PubMed  Google Scholar 

  82. Proudfoot AEI, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, Borlat F, Wells TNC, Kosco-Vilbois MH (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Nat Acad Sci USA 100: 1885–1890

    Article  CAS  PubMed  Google Scholar 

  83. Lau EK, Paavola CD, Johnson Z, Gaudry J-P, Geretti E, Borlaat F, Kungl AJ, Proudfoot AE, Handel TM (2004) Identification of glycosaminoglycan binding site of the CC chemokine, MCP-1; implications for structure and function in vivo. J Biol Chem 279: 22294–22305

    CAS  PubMed  Google Scholar 

  84. Johnson Z, Kosco-Vilbois MH, Herren S, Cirillo R, Muzio V, Zaratin P, Carbonatto M, Mack M, Smailbegovic A, Rose M et al (2004) Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J Immunol 173: 5776–5785

    CAS  PubMed  Google Scholar 

  85. Smit MJ, Vink C, Verzijl D, Casarosa P, Bruggeman CA, Leurs R (2003) Virally encoded G protein-coupled receptors: Targets for potentially innovative anti-viral drug development. Curr Drug Targets 4: 431–441

    Article  CAS  PubMed  Google Scholar 

  86. Yang BT, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW et al (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi’s Sarcoma. J Exp Med 191: 445–454

    Article  CAS  PubMed  Google Scholar 

  87. Streblow DN, Orloff SL, Nelson JA (2001) The HCMV chemokine receptor US28 is a potential target in vascular disease. Curr Drug Target Infect Dis 1: 151–158

    CAS  Google Scholar 

  88. Streblow DN, Vomaske J, Smith P, Melnychuk R, Hall L, Pancheva D, Smit M, Casarosa P, Schlaepfer DD, Nelson JA (2003) Human cytomegalovirus chemokine receptor US28-induced dsmooth muscle cell migration is mediated by focal adhesion kinase and Src. J Biol Chem 278: 50456–50465

    Article  CAS  PubMed  Google Scholar 

  89. Melnychuk RM, Streblow DN, Smith PP, Hirsch AJ, Pancheva D, Nelson JA (2004) Human cytomegalovirus-encoded G protein-coupled receptor US28 mediates smooth muscle cell migration through Galpha12. J Virol 78: 8283–8391

    Article  Google Scholar 

  90. Luttichau BH, Stine J, Boesen TP, Johnsen AH, Chanry D, Gerstoft J, Schwartz TW (2000) A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus Molluscum Contagiosum. J Exp Med 191: 171–180

    Article  CAS  PubMed  Google Scholar 

  91. Luttichau HR, Gerstoft J, Schwartz TW (2001) MC148 encoded by human molluscum contagiosum poxvirus is an antagonist for human but not murine CCR8. J Leukocyte Biol 70: 277–282

    CAS  PubMed  Google Scholar 

  92. Laing KJ, Secombes CJ (2004) Chemokines. Dev Compar Immunol 28: 443–460

    CAS  Google Scholar 

  93. Haque NS, Fallon JT, Pan JJ, Taubman MB, Harpel PC (2004) Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 103: 1296–1304

    CAS  PubMed  Google Scholar 

  94. Littichau HR, Lewis IC, Gerstoft J, Schwartz TW (2001) The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 31: 1217–1220

    Google Scholar 

  95. Spinetti G, Bernardini G, Camarda G, Mangoni A, Santoni A, Capogrossi MC, Napolitano M (2003) The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway. J Leukocyte Biol 73: 201–207

    CAS  PubMed  Google Scholar 

  96. Zhou N, Luo Z, Luo J, Hall JW, Huang Z (2000) A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Biochem 39: 3782–3787

    CAS  Google Scholar 

  97. Shan LX, Qiao XD, Oldham E, Catron D, Kaminski H, Lundell D, Zlotnik A, Gustafson E, Hedrick JA (2000) Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1. Biochem Biophys Res Comm 268: 938–941

    Article  CAS  PubMed  Google Scholar 

  98. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttchau HR, Gerstoft J, Clapham PR et al (1997) A broad-spectrum chemokine antagonist encoded by Kaposi’s sarcoma-associated herpesvirus. Science 277: 1656–1659

    Article  CAS  PubMed  Google Scholar 

  99. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW et al (1997) Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278: 290–294

    Article  CAS  PubMed  Google Scholar 

  100. Sozzani S, Luini W, Bianchi G, Allavena P, Wells TN, Napolitano M, Bernardini G, Vecchi A, D’Ambrosio D, Mazzeo D et al (1998) The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92: 4036–4039

    CAS  PubMed  Google Scholar 

  101. Nakano K, Isegawa Y, Zou P, Tadagaki K, Inagi R, Yamanishi K (2003) Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch Virol 145: 871–890

    Google Scholar 

  102. deBruyne LA, Li K, Bishop DK, Bromberg JS (2000) Gene transfer of virally encoded chemokine antagonists vMIP-11 and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity. Gene Ther 7: 575–582

    Article  CAS  PubMed  Google Scholar 

  103. Weber KSC, Grone HJ, Rocken M, Klier C, Gu SH, Wank R, Proudfoot AEI, Nelson PJ, Weber C (2001) Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur J Immunol 31: 2458–2466

    Article  CAS  PubMed  Google Scholar 

  104. Damon I, Murphy PM, Moss B (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proc Nat Acad Sci USA 95: 6403–6407

    Article  CAS  PubMed  Google Scholar 

  105. Liwang AC, Wang Z-X, Sun Y, Peiper SC, Liwang PJ (1999) The solution structure of the anti-HIV chemokine vMIP-II. Protein Sci 8: 2270–2280

    CAS  PubMed  Google Scholar 

  106. Gerard C, Rollins BJ (2001) Chemokines and disease. Nature Immunol 2: 108–115

    CAS  Google Scholar 

  107. Tran PB, Miller RJ (2003) Chemokine receptors: Signposts to brain development and disease. Nature Rev Neurosci 4: 444–455

    CAS  Google Scholar 

  108. Minami M, Satoh M (2003) Chemokines and their receptors in the brain: Pathophysiological roles in ischemic brain injury. Life Sci 74: 321–327

    Article  CAS  PubMed  Google Scholar 

  109. Takami S, Minami M, Nagata I, Namura S, Satoh M (2001) Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 21: 1430–1435

    CAS  PubMed  Google Scholar 

  110. Ghirnikar RS, Lee YL, Eng LF (2000) Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat. J Neurosci Res 59: 63–73

    Article  CAS  PubMed  Google Scholar 

  111. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK et al (1998) In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attention of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 188: 193–198

    CAS  PubMed  Google Scholar 

  112. Lindow M, Nansen A, Bartholdy C, Stryhn A, Hansen NJV, Boesen TP, Wells TNC, Schwartz TW, Thomsen AR (2003) The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation. J Virol 77: 7393–7400

    Article  CAS  PubMed  Google Scholar 

  113. Singh UP, Singh S, Ravichandran P, Taub DD, Lillard JW Jr (2004) Viral acrophage-inflammatory protein-II: A viral chemokine that differentially affects adaptive mucosal immunity compared with its mammalian counterparts. J Immunol 173: 5509–5516

    CAS  PubMed  Google Scholar 

  114. Fruh K, Simmen K, Luukkonen BGM, Bell YC, Ghazal P (2001) Virogenomics: A novel approach to antiviral drug discovery. Res Focus Rev 6: 621–627

    CAS  Google Scholar 

  115. DeFilippis V, Raggo C, Moses A, Fruh K (2003) Functional genomics in virology and antiviral drug discovery. Trends Biotech 21: 452–457

    CAS  Google Scholar 

  116. Kellam P (2001) Post-genomic virology: The impact of bioinformatics, microarrays and proteomics on investigating host and pathogen interactions. Rev Med Virol 11: 313–329

    Article  CAS  PubMed  Google Scholar 

  117. Anderson NG, Gerin JL, Anderson NL (2003) Global screening for human viral pathogens. Emerg Infect Dis 9: 768–773

    PubMed  Google Scholar 

  118. Pyo R, Jensen KK, Wiekowski MT, Manfra D, Alcami A, Taubman MB, Lira SA (2004) Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine binding protein M3. Am J Pathol 164: 2289–2297

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BioTherapeutics Research Group, University of Western Ontario, London, Ontario, Canada, N6G 2K5

    Alexandra Lucas, Dana McIvor & Grant McFadden

  2. Vascular Biology Research Group, Robarts Research Institute, University of Western Ontario, London, Ontario, Canada, N6G 2K5

    Alexandra Lucas & Dana McIvor

  3. Dept. Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada, N6G 2K5

    Alexandra Lucas, Dana McIvor & Grant McFadden

Authors
  1. Alexandra Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana McIvor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Grant McFadden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Cell Biology, University of Bern, Baltzerstrasse 4, 3012, Bern, Switzerland

    Bernhard Moser

  2. NitroMed, Inc., 12 Oak Park Drive, Bedford, MA, 01730, USA

    Gordon L. Letts

  3. Bone and Inflammation, Eli Lilly and Company Lilly Corporate Center, Indianapolis, IN, 46285, USA

    Kuldeep Neote

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Lucas, A., McIvor, D., McFadden, G. (2006). Virus-encoded chemokine modulators as novel anti-inflammatory reagents. In: Moser, B., Letts, G.L., Neote, K. (eds) Chemokine Biology — Basic Research and Clinical Application. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7423-3_11

Download citation

Publish with us

Policies and ethics

Search

Navigation